Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays the software revision number as v3.6.5, replacing the previous v3.6.4. This reflects a site software update for the page.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new software revision tag (v3.6.4) replaces the previous tag (v3.6.3) in the study record history.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.3 was added to the history, replacing the previous v3.6.2. This reflects an updated page revision in the study record.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Record History now shows the latest revision as v3.6.2 and removes the previous v3.6.0 entry, updating the page's version label.SummaryDifference0.1%

- Check78 days agoChange DetectedThe study history now includes a new revision labeled v3.6.0 with the recruitment status updated to not currently recruiting participants. The previous revision entry v3.5.5 appears to have been removed from the history.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page history shows a newer revision version, updating from v3.5.4 to v3.5.5, indicating a small metadata update to the page history rather than a change to core study information.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.